Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy

The non-interventional Phase IV PROVE study (NCT03208660) assessed retention, efficacy, safety and tolerability, and perampanel dosing in patients with epilepsy during routine clinical care. This analysis evaluated final data from patients aged

Saved in:
Bibliographic Details
Published in:European journal of paediatric neurology 2024-05, Vol.50, p.23-30
Main Authors: Moretz, Katherine, Wheless, James, Santos, Cesar, Segal, Eric, Lancman, Marcelo, Patten, Anna, Malhotra, Manoj
Format: Article
Language:English
Subjects:
Anti-seizure medication
Anticonvulsants - administration & dosage
Anticonvulsants - therapeutic use
Child
Child, Preschool
Epilepsy
Epilepsy - drug therapy
Female
Humans
Infant
Male
Nitriles
Pediatric
Perampanel
Pyridones - adverse effects
Pyridones - therapeutic use
Real-world
Retrospective Studies
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The non-interventional Phase IV PROVE study (NCT03208660) assessed retention, efficacy, safety and tolerability, and perampanel dosing in patients with epilepsy during routine clinical care. This analysis evaluated final data from patients aged
ISSN:1090-3798
1532-2130
1532-2130
DOI:10.1016/j.ejpn.2024.02.008